Compare Illumina, Inc. (ILMN) vs Unity Software Inc (U) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illumina, Inc. vs Unity Software Inc — how do they compare? Illumina, Inc. trades at $189.51 (market cap $27.94B), while Unity Software Inc trades at $30.54 (market cap $13.01B). The key difference: Illumina, Inc. is far larger — about 2.1× Unity Software Inc's market cap, and Illumina, Inc. is trading nearer its 52-week high, Unity Software Inc nearer its low. Which is the better fit depends on your goals.
| ILMN | U | |
|---|---|---|
Market Cap | $27.94B | $13.01B |
Sector | Health | Technology |
52-Week High | $194.33 | $49.47 |
52-Week Low | $91.00 | $17.13 |
Enterprise Value | $29.33B | $13.11B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Illumina (ILMN) trades at $185.36, down 0.69% on the day, with a bullish technical signal from moving averages. The stock shows strong profitability with a 19.42% net income margin and has beaten EPS estimates for three consecutive quarters. Recent news highlights expansion of the Billion Cell Atlas program and upcoming Q2 2026 earnings on July 30.
Outlook remains positive with 51% analyst buy ratings, though the current price exceeds the $178 consensus target. Key risks include competitive pressure from Roche's new sequencer and China market weakness. Earnings growth and cost control initiatives support upside potential, but valuation multiples suggest limited near-term appreciation.
Unity Software (U) trades at $30.14, up 3.97% in the last session, with a bearish technical signal despite recent momentum. Revenue held at $1.85B in 2025, but net losses narrowed to -$403M, improving margins. Analysts are bullish with a $36.50 consensus target, citing AI-driven advertising potential. Cash flow strengthened with $423M from operations in 2025, though high debt and profitability challenges persist.
The stock offers upside if AI initiatives accelerate revenue growth, but risks include sustained losses and competitive pressure. With 69% buy ratings, Wall Street sees value, yet investors must weigh execution risks against the 21% discount to target.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →About Unity Software Inc
Unity Software Inc provides a software platform for creating and operating interactive, real-time 3D content. The platform can be used to create, run and monetize interactive, real-time 2D and 3D content for mobile phones, tablets, PCs, consoles, and augmented and virtual reality devices. The business is spread across the United States, Greater China, EMEA, APAC and Other Americas, of which key revenue is derived from the EMEA region. The products are used in the gaming industry, architecture and construction sector, animation industry, and designing sector.
Read more on U →
